Status:
COMPLETED
Genetic Testing to Understand and Address Renal Disease Disparities
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Hypertension
Chronic Kidney Disease
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
In this genomic medicine implementation pilot project, the investigators aim to conduct a randomized trial in a network of community health centers and primary care facilities to study processes, effe...
Detailed Description
CKD is most commonly associated with diabetes (40%) and hypertension (28%), and affects 26 million American adults. African ancestry populations with hypertension (HTN) have 2- to 3-fold higher risk o...
Eligibility Criteria
Inclusion
- Ages18-65
- Self-identifies as Black/African American
- History of hypertension
- Patient at a participating site
Exclusion
- History of Chronic Kidney Disease
- History of Diabetes
- Pregnant
- Cognitively impaired/unable to provide consent
- Terminally ill
- Planning to leave area of study permanently during the one year study period
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 12 2018
Estimated Enrollment :
2052 Patients enrolled
Trial Details
Trial ID
NCT02234063
Start Date
November 1 2014
End Date
January 12 2018
Last Update
October 5 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Family Health
New York, New York, United States, 10006
2
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029